THE EFFECTS OF GAVISCON AND METOCLOPRAMIDE IN GASTROESOPHAGEAL REFLUX IN CHILDREN
THE EFFECTS OF GAVISCON AND METOCLOPRAMIDE IN GASTROESOPHAGEAL REFLUX IN CHILDREN
复制标题
DOI：
10.1097/00005176-198607000-00008
复制
发表时间：
1986-07-01
影响因子：
2.9
通讯作者：
HILL, R
中科院分区：
文献类型：
--
作者：
FORBES, D;HODGSON, M;HILL, R
在一项双盲随机对照试验中，对患有胃食管反流（GER）的婴儿和儿童口服甲氧氯普胺（0.5 mg/kg/24 h）和一种液体海藻酸-抗酸化合物。通过24 h食管内pH值监测药物治疗效果。甲氧氯普胺和海藻酸-抗酸复合物均不能减少胃食管反流的发生频率或持续时间。
Oral metoclopramide (0.5 mg/kg/24 h) and a liquid alginic acid-antacid compound were administered to infants and children with gastroesophageal reflux (GER) in a double-blind randomized controlled trial. The effect of medication was measured with 24-h intraesophageal pH monitoring. Neither metoclopramide nor the alginic acid-antacid compound decreased the frequency or duration of gastroesophageal reflux.